|
|
Critical Care Medicine
Research Funding
(listed alphabetically by Principal Investigator or by Section faculty member involved)
2006-2008
Role of Ephrins in Lung Edema Due to Virus and Hypoxia
Principal Investigator: Todd C. Carpenter, MD
Source: NHLBI, NIH - 5 R01 HL077743-02
Amount: $1,250,000
Term: 2005 - 2009
PKC Isozymes in Hypoxia-Induced Fibroblast Proliferation
Principal Investigator: Mita Das, PhD
Co-Investigator: Kurt R. Stenmark, MD
Source: NHLBI, NIH - 5 RO1 HL 64917
Amount: $1,250,000
Term: 2001 - 2009
Contribution of Circulating Mononuclear Cells to Hypoxic Pulmonary Vascular Remodeling
Principal Investigator: Maria G. Frid, PhD
Source: AHA - 0550056Z
Amount: $66,000
Term: 2004 - 2007
Extracellular ATP: A Potential Regulator of Hypoxia-Induced Vasa Vasorum Neovascularization
Principal Investigator: Evgenia V. Gerasimovskaya, PhD
Source: AHA Beginning Grant-in-Aid - 0665464Z
Amount: $66,000/yr
Term: 2006 - 2008
Extracellular ATP: Regulator of Hypoxia-Induced Vasa Vasorum Neovascularization
Principal Investigator: Evgenia V. Gerasimovskaya, PhD
Source: NHLBI, NIH - R01 HL 086783-01A2
Amount: $385,000/yr
Term: 2008 - 2013
Extracellular Superoxide Induces Egr-1 in the Hypoxic Pulmonary Artery
Principal Investigator: Eva N. Grayck, MD
Co-Investigator: Kurt R. Stenmark, MD
Source: NHLBI, NIH - 1 R01 HL086680-01A2
Amount: $385,000/yr
Term: 2007 - 2012
Exracellular Superoxide Promotes Neonatal Chronic Hypoxia-Induced Pulmonary Vascular Remodeling
Principal Investigator: Eva N. Grayck, MD
Source: March of Dimes Birth Defects Foundation - 6-FY06-316
Amount: $248,290/yr
Term: 2006 - 2009
S-Nitrosylation of Alpha-1-Adrenergic Receptors in the Lung
Principal Investigator: Eva N. Grayck, MD
Source: NIH - HL 70088-05
Amount: $580,000
Term: 2002 - 2007
Impaired Angiogenic Signaling in Bronchopulmonary Dysplasia
Principal Investigator: Peter M. Mourani, MD
Source: TCH Research Institute
Amount: $30,000
Term: 2006 - 2008
Impaired Angiogenic Signaling in Bronchopulmonary Dysplasia
Principal Investigator: Steven H. Abman, MD
Major Investigator: Peter M. Mourani, MD
Source: NHLBI, NIH - R01 HL085703
Amount: $465,815/yr
Term: 2007 - 2012
Pathogenetic Mechanisms of Bronchopulmonary Dysplasia**
Principal Investigator: Peter M. Mourani, MD
Co-Investigator: Kurt R. Stenmark, MD
Source: NCRR, NIH - 1- K23 RR021921
Amount: $688,148
Term: 2005 - 2010
Adaptation to Hypoxia
Principal Investigator: Kurt R. Stenmark, MD
Source: NHLBI, NIH - HL14985
Amount: $7,538,969
Term: 2003 - 2009
- Project 2: Hypoxia Induces Pulmonary Fibroblast Differentiation
Principal Investigator: Kurt R. Stenmark, MD
Co-Investigators: Maria G. Frid, PhD, Evgenia V. Gerasimovskaya, PhD, and Raphael Nemenoff, PhD
Amount: $1,146,238
- Project 4: Role of VRAC and Rho in Pulmonary EC Proliferation
Principal Investigator: Kurt R. Stenmark, MD
Amount: $1,193,292
- Adminstrative Core
Principal Investigator: Kurt R. Stenmark, MD
Amount: $600,713
SCCOR Grant: Lung Vascular Disease in Infants and Children: Mechanisms and Treatment*+
Principal Investigator: Kurt R. Stenmark, MD
Source: NHLBI, NIH - P50 HL084923
Amount: $12,345,967
Term: 2006 - 2011
- Project 1: Noninvasive Inhaled NO in Premature Newborns
Principal Investigator: John P. Kinsella, MD
Co-Investigator: Steven H. Abman, MD
Amount: $2,457,532
- Project 3: Advanced Imaging and Diagnostics for Pediatric Pulmonary Hypertension
Principal Investigators: Robin Shandas, PhD, and D. Dunbar Ivy, MD
Amount: $2,271,467
- Project 4: Circulating Fibrocytes in Hyperoxic Lung Vascular Remodeling
Principal Investigator: Kurt R. Stenmark, MD
Co-Investigators: Maria Frid, PhD, and Eva N. Grayck, MD
Amount: $2,038,122
- Project 5: Hypoxia-Inducible Factors in Neonatal Pulmonary Hypertension
Principal Investigator: Carl W. White, MD
Co-Investigators: Aftab Ahmad, PhD, Steven H. Abman, MD, and Theresa R. Grover, MD
Amount: $2,686,424
- Core A: Administrative Core
Principal Investigator: Kurt R. Stenmark, MD
Amount: $531,250
- Core B: Noninvasive Inhaled Nitric Oxide in Premature Newborns
Principal Investigator: Ling-Yi, Chang, MD
Co-Investigator: Steven H. Abman, MD
Amount: $795,448
- Core C: Clinical Research Skills Development Core
Principal Investigator: Steven H. Abman, MD
Amount: $531,222
SCOR Grant: The Impact of Injury on the Immature Pulmonary Circulation*
Principal Investigator: Kurt R. Stenmark, MD
Source: NHLBI, NIH - P50 HL 57144
Amount: $6,415,929
Term: 2001 - 2006
- Project I: G-Proteins in Hypoxic Pulmonary Vascular Remodeling
Principal Investigator: Kurt R. Stenmark, MD
Amount: $2,076,662
- Project II: Inhaled NO and the Prevention of BPD
Principal Investigator: Steven H. Abman, MD
Co-Investigator: John P. Kinsella, MD
Amount: $1,860,606
- Project III: Prx Homeobox Genes in Pulmonary Vascular Homeostasis
Principal Investigator: Peter L. Jones, PhD
Amount: $1,456,087
- Clinical Core
Principal Investigator: John P. Kinsella, MD
Co-Investigator: Steven H. Abman, MD
Amount: $481,196
- Administrative Core
Principal Investigator: Kurt R. Stenmark, MD
Amount: $446,045
Training Grant: Respiration and Circulation During Hypoxia
Principal Investigator: Kurt R. Stenmark, MD
Source: NHLBI, NIH - 5 T32 HL-007171-32
Amount: $377,761/yr
Term: 1976 - 2012
Training Grant: Academic Training Program in Pediatric Pulmonary Diseases++
Principal Investigator: Steven H. Abman, MD
Mentor: Kurt R. Stenmark, MD
Source: NHLBI, NIH - 5 T32 HL07670
Amount: $1,878,079
Term: 1999 - 2009
Training Grant: Multidisciplinary Respiratory Diseases Research Training
Principal Investigator: Marvin Schwarz, MD
Mentor: Kurt R. Stenmark, MD
Source: NHLBI, NIH - 5 T32 HL07085
Amount: $892,350/yr
Term: 2005 - 2010
2005
Effects of Virus and Hypoxia on Lung Endothelin and Edema
Principal Investigator: Todd C. Carpenter, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - K01-8 AL04424-02
Amount: $631,000
Term: 2000-2005
PKC Isozymes in Hypoxia-Induced Fibroblast Proliferation
Principal Investigator: Mita Das, PhD
Co-Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - RO1 HL 64917-01A1
Amount: $1,250,000
Term: 2001-2009
Effects of HFOV and iNO in Acute Respiratory Failure in Pediatrics**
Principal Investigator: Emily L. Dobyns, MD
Source: National Institutes of Health, National Center for Research Resources - 5 K23RR16178-03
Amount: $640,190
Term: 2000-2005
Exracellular Superoxide Promotes Neonatal Chronic Hypoxia-Induced Pulmonary Vascular Remodeling
Principal Investigator: Eva N. Grayck, MD
Source: March of Dimes
Amount: $248,290
Term: 2006-2009
S-Nitrosylation of Alpha-1-Adrenergic Receptors in the Lung
Principal Investigator: Eva N. Grayck, MD
Source: National Institutes of Health - HL70088-05
Amount: $580,000
Term: 2002-2007
Nitric Oxide and G Protein-Coupled Alpha-1-Adrenergic and 5-HT Receptor Function in the Pulmonary Vasculature
Principal Investigator: Eva N. Grayck, MD
Source: American Lung Association - RG-139-N
Amount: $70,000
Term: 2003-2005
Respiration and Circulation During Hypoxia
Principal Investigator: Ivan F. McMurty, PhD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - T32HL07171
Amount: $308,688/yr
Term: 2002-2007
SCOR Grant: The Impact of Injury on the Immature Pulmonary Circulation*
Principal Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - P50 HL 57144
Amount: $6,415,929
Term: 2001-2006
- Project I: G-Proteins in Hypoxic Pulmonary Vascular Remodeling
Principal Investigator: Kurt R. Stenmark, MD
Amount: $2,076,662
- Project II: Inhaled NO and the Prevention of BPD
Principal Investigator: Steven H. Abman, MD
Co-Investigator: John P. Kinsella, MD
Amount: $1,860,606
- Project III: Prx Homeobox Genes in Pulmonary Vascular Homeostasis
Principal Investigator: Peter L. Jones, PhD
Amount: $1,456,087
- Clinical Core
Principal Investigator: John P. Kinsella, MD
Co-Investigator: Steven H. Abman, MD
Amount: $481,196
- Administrative Core
Principal Investigator: Kurt R. Stenmark, MD
Amount: $543,369
Hypoxia Induces Pulmonary Fibroblast Differentiation
Principal Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - HL14985
Amount: $1,250,000
Term: 2003-2008
Project II in Program Project Grant: Adaptation to Hypoxia. Hypoxia Induces Pulmonary Fibroblast Differentiation
Principal Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - HL 14985
Amount: $1,146,238
Term: 2003-2008
Role of Ephrins in Lung Edema Due to Virus and Hypoxia
Principal Investigator: Todd Carpenter, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - 1 R01 HL077743-01
Amount: $1,250,000
Term: 2005-2009
Pathogenetic Mechanisms of Bronchopulmonary Dysplasia (K23)
Principal Investigator: Peter M. Mourani, MD
Source: National Institutes of Health, National Center for Research Resources
Amount: $688,148
Term: 2005-2010
2003-2004
Effects of Virus and Hypoxia on Lung Endothelin and Edema
Principal Investigator: Todd C. Carpenter, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - K01-8 AL04424-02
Amount: $631,000
Term: 2000-2005
PKC Isozymes in Hypoxia-Induced Fibroblast Proliferation
Principal Investigator: Mita Das, PhD
Co-Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - RO1 HL 64917-01A1
Amount: $1,250,000
Term: 2001-2006
Effects of HFOV and iNO in Acute Respiratory Failure in Pediatrics**
Principal Investigator: Emily L. Dobyns, MD
Source: National Institutes of Health, National Center for Research Resources - 5 K23RR16178-03
Amount: $640,190
Term: 2000-2005
Mentored Clinician-Scientist Development Award
S-Nitrosylation of Alpha-1-Adrenergic Receptors in the Lung
Principal Investigator: Eva N. Grayck, MD
Source: National Institutes of Health - HL70088-05
Amount: $580,000
Term: 2002-2007
Nitric Oxide and G Protein-Coupled Alpha-1-Adrenergic and 5-HT
Receptor Function in the Pulmonary Vasculature
Principal Investigator: Eva N. Grayck, MD
Source: American Lung Association
- RG-139-N
Amount: $70,000
Term: 2003-2005
A Randomized, Open-Label, Multicenter, Multinational,
Dose-Ranging Study of the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics
of Recombinant Human
Acid Alpha-Glucosidase (rhGAA) Treatment in Patients < 6 Months Old with Infantile-Onset
Glycogen Storage Disease Type II
Co-Investigators: Eva N. Grayck, MD, and Priya
Kishnani, MD
Source: Genzyme Corporation - AGLU01602
Term: 2003-2004
An Open-Label, Multicenter, Multinational, Study of the
Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Recombinant Human
Acid Alpha-Glucosidase (rhGAA) Treatment
in Patients > 6 and 36 Months Old with Infantile-Onset Pompe Disease
Co-Investigators: Eva N. Grayck, MD, and Priya Kishnani, MD
Source: Genzyme Corporation - AGLU01702
Term: 2003-2004
Prx Homeobox Genes in Pulmonary Vascular Homeostasis
Principal Investigator: Peter L. Jones, PhD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - 1 R01 HL68798-01
Amount: $375,000
Term: 2001-2006
Giles Filley Memorial Award for Excellence in Respiratory Medicine
Principal Investigator: Peter L. Jones, PhD
Source:American Physiological Society
Amount: $20,000
Term: 2003-2004
Respiration and Circulation During Hypoxia
Principal Investigator: Ivan F. McMurty, PhD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - T32HL07171
Amount: $308,688/yr
Term: 2002-2007
SCOR Grant: The Impact of Injury on the Immature Pulmonary Circulation*
Principal Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - P50 HL 57144
Amount: $6,415,929
Term: 2001-2006
- Project I: G-Proteins in Hypoxic Pulmonary Vascular Remodeling
Principal Investigator: Kurt R. Stenmark, MD
Amount: $2,076,662
- Project II: Inhaled NO and the Prevention of BPD
Principal Investigator: Steven H. Abman, MD
Co-Investigator: John P. Kinsella, MD
Amount: $1,860,606
- Project III: Prx Homeobox Genes in Pulmonary Vascular Homeostasis
Principal Investigator: Peter L. Jones, PhD
Amount: $1,456,087
- Clinical Core
Principal Investigator: John P. Kinsella, MD
Co-Investigator: Steven H. Abman, MD
Amount: $481,196
- Administrative Core
Principal Investigator: Kurt R. Stenmark, MD
Amount: $543,369
Hypoxia Induces Pulmonary Fibroblast Differentiation
Principal Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - HL14985
Amount: $1,250,000
Term: 2003-2008
Project II in Program Project Grant: Adaptation to Hypoxia. Hypoxia Induces Pulmonary Fibroblast Differentiation
Principal Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - HL 14985
Amount: $1,146,238
Term: 2003-2008
Role of Novel Embryonic Genes in SMC Growth after Vascular Injury
Principal Investigator: Mary C. M. Weiser-Evans, PhD
Co-Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - RO1 HL 63946-01A1
Amount: $1,280,731
Term: 2000-2004
Role of PTEN in Vascular Smooth Muscle Cell Growth Inhibition
Principal Investigator: Mary C. M. Weiser-Evans, PhD
Source: University of Colorado Cancer Center Seed Grant
Amount: $20,000
Term: 2002-2003
2001-2002
Neprilysin and Endothelin: Interactions with Viral Infection and Hypoxia in Pulmonary Edema Formation
Principal Investigator: Todd Carpenter, MD
Source: American Heart Association Desert/Mountain Affiliate
Amount: $60,000
Term: 1999-2001
Effects of Virus and Hypoxia on Lung Endothelin and Edema
Principal Investigator: Todd Carpenter, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - K01-8 AL04424-02
Amount: $631,000
Term: 2000-2005
PKC Isozymes in Hypoxia-Induced Fibroblast Proliferation
Principal Investigator: Mita Das, PhD
Co-Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - RO1 HL 64917-01A1
Amount: $1,250,000
Term: 2001-2006
Effects of HFOV and iNO in Acute Respiratory Failure in Pediatrics**
Principal Investigator: Emily L. Dobyns, MD
Source: National Institutes of Health, National Center for Research Resources - 5 K23RR16178-03
Amount: $640,190
Term: 2000-2005
Molecular Determinants of Tenascin-C Expression in Vascular Smooth Muscle Cells
Principal Investigator: Peter L. Jones, PhD
Source: American Heart Association, National Grant-In-Aid
Amount: $165,000
Term: 1999-2003
Prx Homeobox Genes in Pulmonary Vascular Homeostasis
Principal Investigator: Peter L. Jones, PhD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - 1 R01 HL68798-01
Amount: $375,000
Term: 2001-2006
SCOR Grant: The Impact of Injury on the Immature Pulmonary Circulation*
Principal Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - P50 HL 57144
Amount: $6,415,929
Term: 2001-2006
- Project I: G-Proteins in Hypoxic Pulmonary Vascular Remodeling
Principal Investigator: Kurt R. Stenmark, MD
Amount: $2,076,662
- Project II: Inhaled NO and the Prevention of BPD
Principal Investigator: Steven H. Abman, MD
Co-Investigator: John P. Kinsella, MD
Amount: $1,860,606
- Project III: Prx Homeobox Genes in Pulmonary Vascular Homeostasis
Principal Investigator: Peter L. Jones, PhD
Amount: $1,456,087
- Clinical Core
Principal Investigator: John P. Kinsella, MD
Co-Investigator: Steven H. Abman, MD
Amount: $481,196
- Administrative Core
Principal Investigator: Kurt R. Stenmark, MD
Amount: $543,369
SCOR Grant: The Impact of Injury on the Immature Pulmonary Circulation*
Principal Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - P50 HL 57144
Amount: $7,145,567
Term: 1996-2001
- Project I: SMC Heterogeneity in the Pulmonary Vasculature
Principal Investigator: Kurt R. Stenmark, MD
Amount: $1,324,572
- Project II: Perlecan Heparan Sulfates: Molecular Mechanisms Underlying the Control of Vascular Smooth Muscle Cell Replication and Gene Expression During Normal Development and in Neonatal Pulmonary Hypertension
Principal Investigator: Kurt R. Stenmark, MD
Co-Investigator: Mary C. M. Weiser-Evans, PhD
Amount: $962,228
- Project III: NO-cGMP Cascade in Neonatal Pulmonary Hypertension
Principal Investigator: Steven H. Abman, MD
Co-Investigator: John P. Kinsella, MD
Co-Investigators Clinical Core: John P. Kinsella, MD, and Steven H. Abman, MD
Amount: $1,960,576
- Project IV: Oxidants, Energy and Pulmonary Vascular Development
Principal Investigator: Carl W. White, MD
Amount: $657,184
- Clinical Core
Principal Investigator: Adam A. Rosenberg, MD
Amount: $1,376,432
- Administrative Core
Principal Investigator: Kurt R. Stenmark, MD
Amount: $371,168
Project II in Program Project Grant: Adaptation to Hypoxia. Distinct Mechanisms of Growth Control in Select SMC Subpopulations
Principal Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - HL 14985
Amount: $1,137,299
Term: 1998-2003
Growth Suppressive Mechanisms in Vascular SMC
Principal Investigator: Mary C. M. Weiser-Evans, PhD
Source: American Heart Association
Amount: $165,000
Term: 1999-2001
Role of Novel Embryonic Genes in SMC Growth after Vascular Injury
Principal Investigator: Mary C. M. Weiser-Evans, PhD
Co-Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute - RO1 HL 63946-01A1
Amount: $1,280,731
Term: 2000-2004
Role of PTEN in Vascular Smooth Muscle Cell Growth Inhibition
Principal Investigator: Mary C. M. Weiser-Evans, PhD
Source: University of Colorado Cancer Center Seed Grant
Amount: $20,000
Term: 2002-2003
1999-2000
The Roles of Neutral Endopeptidase and Endothelin in Hypoxia-Induced Pulmonary Edema
Principal Investigator: Todd Carpenter, MD
Source: American Heart Association of Colorado and Wyoming
Amount: $25,000
Term: July 1998-June 1999
Neprilysin and Endothelin: Interactions with Viral Infection and Hypoxia in Pulmonary Edema Formation
Principal Investigator: Todd Carpenter, MD
Source: American Heart Association Desert/Mountain Affiliate
Amount: $60,000
Term: July 1999-June 2001
Effects of Virus and Hypoxia on Lung Endothelin and Edema
Principal Investigator: Todd Carpenter, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute
Amount: $631,000
Term: September 2000-July 2005
Cellular Mechanisms of Interaction Between Viral Infection and Hypoxia in the Development of Pulmonary Edema
Principal Investigator: Todd Carpenter, MD
Source: Professional Development Award, The Children's Hospital Research Institute
Amount: $70,000
Term: March 1999-February 2000
Adventitial Remodeling in Neonatal Pulmonary Hypertension
Principal Investigator: Mita Das, PhD
Source: American Lung Association
Amount: $50,000
Term: July 1998-June 2000
Effects of HFOV and iNO in Acute Respiratory Failure in Pediatrics**
Principal Investigator: Emily Dobyns, MD
Source: National Center for Research Resources - K23 [National Institutes of Health]
Amount: $640,190
Term: 2000-2005
Physiologic and Cellular Interactions of Parainfluenza Virus and Hypoxia on the Development of Lung Edema
Principal Investigator: Anthony G. Durmowicz, MD
Source: The Children's Hospital Research Institute
Amount: $40,000
Term: July 1998-June 1999
Project III in Program Project Grant: Adaptation to Hypoxia. Distinct Mechanisms of Growth Control in Select SMC Subpopulations
Principal Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute
Amount: $1,137,299
Term: April 1998-March 2003
SCOR Grant: Impact of Injury on the Immature Pulmonary Circulation
Principal Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute
Amount: $7,145,567
Term: December 1996-November 2001
SCOR Grant: Impact of Injury on the Immature Pulmonary Circulation. Project I: SMC Heterogeneity in the Pulmonary Vasculature
Principal Investigator: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute
Amount: $1,324,572
Term: December 1996-November 2001
SCOR Grant: Impact of Injury on the Immature Pulmonary Circulation. Project II: Perlecan Heparan Sulfates: Molecular Mechanisms Underlying the Control of Vascular Smooth Muscle Cell Replication and Gene Expression During Normal Development and in Neonatal Pulmonary Hypertension
Principal Investigator: Kurt R. Stenmark, MD
Co-Investigator: Mary C.M. Weiser, PhD
Source: National Institutes of Health, National Heart, Lung and Blood Institute
Amount: $962,228
Term: December 1996-November 2001
The IGF Axis in Neonatal Pulmonary Vascular Remodeling
Principal Investigator: Susan F. Townsend, MD
Sponsor: Kurt R. Stenmark, MD
Source: National Institutes of Health, National Heart, Lung and Blood Institute
Amount: $385,270
Term: May 1994-April 1999
Role of Novel Embryonic Genes in SMC Growth After Vascular Injury
Principal Investigator: Mary Weiser-Evans, PhD
Source: National Institutes of Health, National Heart, Lung and Blood Institute
Amount: $1,280,731
Term: October 2000-September 2004
Growth Suppressive Mechanisms in Vascular SMC
Principal Investigator: Mary Weiser-Evans, PhD
Source: American Heart Association
Amount: $165,000
Term: 1999-2001
Matrix-Injury Regulated Expression of Serum Response Factor in Vascular SMC
Principal Investigator: Mary Weiser-Evans, PhD
Source: American Heart Association
Amount: $132,000
Term: 1996-1999
|
|
